Anesthesia Knowledge Test 24 (AKT-24) Practice

The believed benefit of hemodilution in treating subarachnoid hemorrhage (SAH) patients is that it enhances microvascular perfusion. Hemodilution involves reducing the concentration of blood cells by increasing plasma volume, typically through intravenous fluids. This process lowers blood viscosity, which can improve the flow of blood through the microcirculation.

In the context of SAH, where patients often face complications such as vasospasm and ischemia, improved microvascular perfusion is crucial for delivering adequate oxygen and nutrients to the brain tissue. By enhancing perfusion in the microvasculature, hemodilution may help mitigate the secondary injury associated with SAH, ultimately leading to better clinical outcomes. Therefore, the primary focus of hemodilution in these patients is its capacity to facilitate improved blood flow, especially in the delicate vascular structures of the brain.